SHCBP1 and skin neoplasm: Recently, in a study of skin cancer, Huang et al. 31 found that overexpression of SHCBP1 was able to significantly reduce the anti-inflammatory effect of Oroxylin A and speculated that SHCBP1 may be involved in the regulation of inflammatory responses during skin carcinogenesis.